These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 36059609)

  • 1. Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications.
    Zhou X; Ao X; Jia Z; Li Y; Kuang S; Du C; Zhang J; Wang J; Liu Y
    Front Oncol; 2022; 12():951864. PubMed ID: 36059609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance.
    Liu Y; Ao X; Wang Y; Li X; Wang J
    Front Oncol; 2022; 12():841411. PubMed ID: 35155266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of non-coding RNAs in gastric cancer.
    Yang Q; Zhang RW; Sui PC; He HT; Ding L
    World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-coding RNAs as Novel Biomarkers in Cancer Drug Resistance.
    Yang H; Qi C; Li B; Cheng L
    Curr Med Chem; 2022; 29(5):837-848. PubMed ID: 34348605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications.
    Chen D; Ping S; Xu Y; Wang M; Jiang X; Xiong L; Zhang L; Yu H; Xiong Z
    Front Cell Dev Biol; 2021; 9():732036. PubMed ID: 34805143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer.
    Lan H; Yuan J; Zeng D; Liu C; Guo X; Yong J; Zeng X; Xiao S
    Front Genet; 2021; 12():693259. PubMed ID: 34512721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Non-Coding RNAs Inducing Drug Resistance in Ovarian Cancer: A New Perspective for Understanding Drug Resistance.
    Li G; Gong J; Cao S; Wu Z; Cheng D; Zhu J; Huang X; Tang J; Yuan Y; Cai W; Zhang H
    Front Oncol; 2021; 11():742149. PubMed ID: 34660304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Non-Coding RNAs on Chemotherapeutic Resistance in Oral Cancer.
    Yamaguchi K; Yamamoto T; Chikuda J; Shirota T; Yamamoto Y
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer.
    Liu Y; Ao X; Ji G; Zhang Y; Yu W; Wang J
    Front Oncol; 2021; 11():768918. PubMed ID: 34912714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXO3a in cancer drug resistance.
    Liu Y; Wang Y; Li X; Jia Y; Wang J; Ao X
    Cancer Lett; 2022 Aug; 540():215724. PubMed ID: 35545128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma.
    Hu X; Zhu H; Shen Y; Zhang X; He X; Xu X
    Front Oncol; 2021; 11():696705. PubMed ID: 34367979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Coding RNAs: New Biomarkers and Therapeutic Targets for Temporal Lobe Epilepsy.
    Manna I; Fortunato F; De Benedittis S; Sammarra I; Bertoli G; Labate A; Gambardella A
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer.
    Wei L; Sun J; Zhang N; Shen Y; Wang T; Li Z; Yang M
    Front Cell Dev Biol; 2021; 9():764313. PubMed ID: 34881242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications.
    Liu Y; Ding W; Wang J; Ao X; Xue J
    Front Oncol; 2023; 13():1256537. PubMed ID: 37746261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting non-coding RNAs to overcome cancer therapy resistance.
    Chen B; Dragomir MP; Yang C; Li Q; Horst D; Calin GA
    Signal Transduct Target Ther; 2022 Apr; 7(1):121. PubMed ID: 35418578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of cancer drug resistance and the involvement of noncoding RNAs.
    Xia H; Hui KM
    Curr Med Chem; 2014; 21(26):3029-41. PubMed ID: 24735364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics.
    Chen M; Lei N; Tian W; Li Y; Chang L
    Ther Adv Med Oncol; 2022; 14():17588359221118010. PubMed ID: 35983027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncoding RNAs in Drug Resistance of Gastrointestinal Stromal Tumor.
    Li J; Guo S; Sun Z; Fu Y
    Front Cell Dev Biol; 2022; 10():808591. PubMed ID: 35174150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of autophagy by non-coding RNAs in gastric cancer.
    Wang Z; Liu J; Xie J; Yuan X; Wang B; Shen W; Zhang Y
    Front Oncol; 2022; 12():947332. PubMed ID: 36353541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unrevealing the vital role of ncRNAs in Gastric Cancer chemoresistance.
    Kazemi A; Goodarzi M; Daneshipour K; Sarabadani H; Shahpar Z; Hajiagha BS; Kheradjoo H; Mohammadzadehsaliani S
    Pathol Res Pract; 2023 Oct; 250():154761. PubMed ID: 37689003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.